Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET

Private MD News

Home | News | Diabetes

Insulin manufacturer's stock drops

Category: Diabetes

Bloomberg reported that pharmaceutical company Novo Nordisk's stock has dropped by 3.3 percent on Oct. 26, making it the company's largest loss in more than a year, after the U.S. Food and Drug Administration (FDA) announced that it may require the Danish drug maker's newest insulin product, Treisba, to undergo additional studies.

The source noted that medications for diabetes, which can be detected with a lab test, have been monitored more closely by health authorities after it was revealed that GlaxoSmithKline's Avandia increased the risk of heart attacks. The FDA also wrote in a report that analyses of previously conducted studies have shown that Novo Nordisk's product poses more of a risk to heart health, compared to the other products on the market

According to Bloomberg, an analyst at Berenberg Bank wrote that if the FDA rules that Novo must conduct additional studies on the cardiovascular effects of Treisba after its initial approval, it could delay the drug reaching the U.S. market by several years.

"There is no cause for concern based on what we know," Mads Krogsgaard Thomsen, Novo's chief science officer told the news source. "This product is approvable. Whether that is with or without a post-approval cardiovascular outcomes study commitment, it's a different story."

Japanese officials have already approved Treisba, as has a European Advisory board on Oct. 19.


Related Articles from Private MD:

Share on Facebook

Subscribe to Private MD Health News RSS Feed: Subscribe

News Categories:

Advanced Lipid Treatment I   Allergy Testing   Anemia and RBC disorders   Autoimmune Diseases   Bariatric Lab Testing   Blood and Blood Diseases   Breast   Cancer Detection and Tumor Markers   Celiac Disease Testing   Chlamydia   Coagulation and blood clotting disorders   Colon   Diabetes   DNA, Paternity and Genetic testing   Drug Screening   Environmental Toxin Testing   Female Specific Tests   Gastrointestinal Diseases   General Health   General Wellness   Heart Health and Cholesterol   Herpes   HIV   HIV monitoring/Treatment/Testing/Post Diagnos   Hormones and Metabolism   Infectious Diseases   Infertility Testing-Male   Infertitlity Hormone Testing   Kidney Diseases   Leukemia and WBC disorders   Liver   Liver Diseases   Lyme Disease   Male Specific Tests   Menopause/Peri-Menopausal Diagnosis   Musculoskeletal Diseases   Organ Specific Testing   Ovarian   Prostate   Sexually Transmitted Diseases   Thyroid Diseases   Transgender Hormone Testing-female to male   Transgender Hormone Testing-Male to Female   Vitamin D Deficiency-Diagnosis and Treatment   

Visit the Health News Archive: Click Here

Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.

Back to top